vt3989
vivace therapeutics
['concept data', 'vt3989']
sfbn feed: researchers report clinical proof-of-concept data for vivace therapeutics' vt3989, a first for a cancer drug targeting the hippo pathway, in oral presentation at aacr 2023: first-in-class ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs